FI  Lightchain




     Office Locations:

2 Bellerive Country Club Drive
St. Louis, MO 63141

 

Stages:

  • Early


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare
  • Software & Internet

  •  

    Description:

    Lightchain is the family office of Rodger Riney. Riney was the Founder and former CEO of discount brokerage firm Scottrade. According to Forbes, Riney is worth $3.5B. In the year after selling Scottrade, Riney donated $131 million to various causes. Riney actively supports non-profit organizations, including the Alzheimer's Association, the Humane Society of the United States, and the Salvation Army. Riney suffers from multiple myeloma and in 2017, he donated $5 million to fund research on the disease. In 2018, he donated $20 million to the Washington University School of Medicine.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Roger Riney Founder

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      06/16/2020


      C4 Therapeutics


      MA


      $170,000,000


      Series B


      02/04/2020


      Adarza BioSystems


      NY


      $25,000,000


      Series D


      10/02/2019


      Geneoscopy


      MO


      $6,900,000


      Series A


     

    Portfolio companies include:

     

    Recent News: